510(k) Report

510(k) · Cleared

Cleared

Advin Multi-Drug Screen Test Cassette, Dip Card and Cup

K122809510(k) TraditionalCleared Jun 17, 2013277-day reviewClass II21 CFR 862.3100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Advin Biotech · DKZ Enzyme Immunoassay, Amphetamine

Cleared on Jun 17, 2013 as substantially equivalent to K061718 (Innovacon, Inc., 2006) after a 277-day review. Its family tree reaches back 5 generations to 1995. 55 later devices descend from it.

Decided
Jun 17, 2013
Review
277 days
Class
Class II
Product code
DKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K945610 (1995). 26 ancestors in all. 55 later devices descend from it, 12 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2005: 1 other ancestor2004: 3 other ancestors2003: 2 other ancestors2002: 2 other ancestors2001: 7 other ancestors2000: 1 other ancestor1999: 1 other ancestor1998: 1 other ancestor1996: 2 other ancestors2016: 5 descendants cleared2015: 3 descendants cleared2018: 5 descendants cleared2014: 2 descendants cleared2020: 3 descendants cleared2023: 6 descendants cleared2019: 6 descendants cleared2017: 1 descendant cleared2025: 7 descendants cleared2021: 2 descendants cleared2024: 9 descendants cleared2022: 3 descendants cleared2026: 3 descendants clearedK945610 · Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM) Amp, Doa-Amp · Princeton BioMeditech Corp. · 1995K011673 · Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step Amphetamine Test Device · ACON Laboratories, Inc. · 2001K020313 · Acon One Step Multi-Drug Multi-Line Screen Test Card; Acon One Step Multi-Drug Multi-Line Screen Test Device · Acon Laboratories Co. · 2002K031759 · Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card · ACON Laboratories, Inc. · 2003 · recalledK061718 · Innovacon Spectrum II Test Card · Innovacon, Inc. · 2006 · recalled1995200020052010201520202025
  1. Root · 5 generations backK945610 Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM)…Princeton BioMeditech Corp. · 1995
  2. 4 generations backK011673 Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step…ACON Laboratories, Inc. · 2001
  3. 3 generations backK020313 Acon One Step Multi-Drug Multi-Line Screen Test Card; Acon One Step…Acon Laboratories Co. · 2002
  4. 2 generations backK031759 Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon…ACON Laboratories, Inc. · 2003 · Recalled
  5. 1 generation backK061718 Innovacon Spectrum II Test CardInnovacon, Inc. · 2006 · Recalled
  6. This deviceK122809 Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech · 2013
  7. Descendant · cites it directly · 16 of its ownK140748 One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test…Co-Innovation Biotech Co., Ltd. · 2014
  8. Descendant · cites it directly · 13 of its ownK182701 Wondfo T-Cup Multi-Drug Urine Test CupGuangzhou Wondfo Biotech Co., Ltd. · 2018 · Recalled
  9. Descendant · cites it directly · 13 of its ownK142800 Rapid Single/Multi-drug Test Cup and Rapid Single/Multi-drug Test…Co-Innovation Biotech Co., Ltd. · 2014
  10. Descendant · cites it directly · 12 of its ownK181768 AssureTech Panel Dip Tests, AssureTech Quick Cup TestsAssure Tech. (Hangzhou) Co, Ltd. · 2018
  11. Descendant · cites it directly · 11 of its ownK182123 ATTEST Drug Screen Cup, ATTEST Drug Screen Dip CardAdvin Biotech, Inc. · 2019

Showing 5 of 55 descendants. See all descendants

Descendants cleared per year

2014: 22015: 32016: 52017: 12018: 52019: 62020: 32021: 22022: 32023: 62024: 92025: 72026: 3
2014high 9 (2024) · low 1 (2017)2026

Most influential descendants

Showing 5 of 55 · See all
  • K140748One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test DipcardCo-Innovation Biotech Co., Ltd. · 2014 · cites it directly16descendants
  • K182701Wondfo T-Cup Multi-Drug Urine Test CupGuangzhou Wondfo Biotech Co., Ltd. · 2018 · cites it directly13descendants
  • K142800Rapid Single/Multi-drug Test Cup and Rapid Single/Multi-drug Test DipcardCo-Innovation Biotech Co., Ltd. · 2014 · cites it directly13descendants
  • K181768AssureTech Panel Dip Tests, AssureTech Quick Cup TestsAssure Tech. (Hangzhou) Co, Ltd. · 2018 · cites it directly12descendants
  • K182123ATTEST Drug Screen Cup, ATTEST Drug Screen Dip CardAdvin Biotech, Inc. · 2019 · cites it directly11descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K945610Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM) Amp, Doa-AmpPrinceton BioMeditech Corp.1995—
−4K011673Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step Amphetamine Test…ACON Laboratories, Inc.2001—
−3K020313Acon One Step Multi-Drug Multi-Line Screen Test Card; Acon One Step Multi-Drug…Acon Laboratories Co.2002—
−2K031759Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum…ACON Laboratories, Inc.20031
−1K061718Innovacon Spectrum II Test CardInnovacon, Inc.20066
0 (this device)K122809Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech2013—
+1K140748One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test DipcardCo-Innovation Biotech Co., Ltd.2014—
+1K182701Wondfo T-Cup Multi-Drug Urine Test CupGuangzhou Wondfo Biotech Co., Ltd.20181
+1K142800Rapid Single/Multi-drug Test Cup and Rapid Single/Multi-drug Test DipcardCo-Innovation Biotech Co., Ltd.2014—
+1K181768AssureTech Panel Dip Tests, AssureTech Quick Cup TestsAssure Tech. (Hangzhou) Co, Ltd.2018—
+1K182123ATTEST Drug Screen Cup, ATTEST Drug Screen Dip CardAdvin Biotech, Inc.2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199620
199810
199910
200010
200170
200220
200320
200430
200510
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201420
201530
201650
201710
201850
201960
202030
202120
202230
202360
202490
202570
202630
FIG. 1 — Lineage of K122809, 1995–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DKZ device

  1. #1 K233019 AllTest Multi-Drug Rapid Test Cup; AllTest…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061718Innovacon Spectrum II Test Card
Summary page 4
…ic gravity, pH, glutaraldehyde, creatinine and nitrite. : Predicate Devices and 510(k) Numbers: Innovacon Spectrum Il Test Card and Test Card with Integrated Test Cup (K061718) Comparison to a Predicate Device: The ADVIN Multi-Drug Screen Test (Cassette, Dipcard and Cup) have following similarities com…
Innovacon, Inc.20066

Also cleared against K061718: 6 other devices →

What descends from it? (55)

See all 55

12 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140748One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test DipcardCo-Innovation Biotech Co., Ltd.201416
K182701Wondfo T-Cup Multi-Drug Urine Test CupGuangzhou Wondfo Biotech Co., Ltd.201813
K142800Rapid Single/Multi-drug Test Cup and Rapid Single/Multi-drug Test DipcardCo-Innovation Biotech Co., Ltd.201413
K181768AssureTech Panel Dip Tests, AssureTech Quick Cup TestsAssure Tech. (Hangzhou) Co, Ltd.201812
K182123ATTEST Drug Screen Cup, ATTEST Drug Screen Dip CardAdvin Biotech, Inc.201911
K152269Healgen Amphetamine Test (Strip, Cassette, Cup, Dip Card), Healgen Cocaine Test (Strip…Healgen Scientific,, LLC20151
K231137Xenta Drug Screen Cup, Xenta Drug Screen DipcardXenta Biomedical Science Co., Ltd.20230
K201494ATTEST Drug Screen Cup, ATTEST Drug Screen Dip CardAdvin Biotech, Inc.20200
K171695First Sign Multi-Drug Dip Card Test, First Sign Multi-Drug Cup Test, First Sign Drug of…W.H.P.M., Inc.20180
K161214Wondfo Amphetamine Urine Test AMP 500 (Cup, Dipcard), Wondfo Cocaine Urine Test COC…Guangzhou Wondfo Biotech Co., Ltd.20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 5 companies; a new generation was cleared every 3.3 years on median.
  • 2 of the 26 ancestors have a recall of any class.
  • Of its descendants, K140748 (Co-Innovation Biotech Co., Ltd., 2014) has gone furthest, with 16 descendants of its own.
  • 6 other devices also cite its predicate K061718.

How does its category compare?

All DKZ devices

DKZ Enzyme Immunoassay, Amphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DKZ

1in 2024

2008: 22009: 22010: 42011: 62012: 52013: 82014: 82015: 52016: 52018: 32019: 32020: 12023: 22024: 1
2007high 8 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKZ

180in 2019

2010: 233 days median2011: 123 days median2012: 55 days median2013: 103 days median2014: 128 days median2015: 107 days median2016: 215 days median2018: 128 days median2019: 180 days median
2007high 233 (2010) · low 55 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DKZ

1in 2017

2007: 12008: 32009: 52011: 42013: 12014: 32017: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKZ

2in 2025

2008: 122009: 12010: 12011: 22013: 12014: 92015: 82016: 82021: 32022: 42023: 72024: 12025: 2
2007high 12 (2008) · low 0 (2007)2025

MAUDE reports naming product code DKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20082—312
20092—51
2010423301
2011612342
201255500
2013810311
2014812839
2015510708
2016521508
20170—10
2018312800
2019318000
20201—00
20210—03
20220—04
20232—07
20241—01
20250—02
20260—0—

What is it indicated for?

The Advin Multi-Drug Screen Test is a one-step immunoassay for the qualitative detection of multiple drugs of abuse and/or their metabolites in human urine at the following cutoff levels: Drug Test — Calibrator — Cutoff Level Amphetamine (AMP) — d-Amphetamine — 500 ng/mL Barbiturates (BAR) — Secobarbital — 300 ng/mL Benzodiazepines (BZO) — Oxazepam — 300 ng/mL Buprenorphine (BUP) — Buprenorphine — 10 ng/mL Cocaine (COC) — Benzoylecgnine — 150 ng/mL EDDP…

Read the full statement (342 words)

The Advin Multi-Drug Screen Test is a one-step immunoassay for the qualitative detection of multiple drugs of abuse and/or their metabolites in human urine at the following cutoff levels:

Drug Test — Calibrator — Cutoff Level

Amphetamine (AMP) — d-Amphetamine — 500 ng/mL

Barbiturates (BAR) — Secobarbital — 300 ng/mL

Benzodiazepines (BZO) — Oxazepam — 300 ng/mL

Buprenorphine (BUP) — Buprenorphine — 10 ng/mL

Cocaine (COC) — Benzoylecgnine — 150 ng/mL

EDDP — 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine — 300 ng/mL

Ecstasy (MDMA) — Methylenedioxymethamphetamine — 500 ng/mL

Methamphetamine (MET) — d-Methamphetamine — 500 ng/mL

Methadone (MTD) — Methadone — 300 ng/mL

Morphine (MOR300) — Morphine — 300 ng/mL

Opiates (OPI) — Morphine — 2,000 ng/mL

Oxycodone (OXY) — Oxycodone — 100 ng/mL

Phencyclidine (PCP) — Phencyclidine — 25 ng/mL

Propoxyphene (PPX) — Propoxyphene — 300 ng/mL

Tricyclic-antidepressant (TCA) — Nortriptynine — 1,000 ng/mL

Marijuana (THC) — 1-nor-A9-THC-9-COOH — 50 ng/mL

The Advin Multi-Drug Screen Test consists of three formats: a Cassette, a Dip Card and a Cup, which may be configured in any combination of the drug analytes listed in the above table.

Advin Multi-Drug Screen Test is used to obtain a visual, qualitative, preliminary test result for prescription use in point of care sites, laboratory settings and is also intended for workplace and over-the-counter use. The Propoxyphene test strip is not intended for over-the-counter use.

The Advin Multi-Drug Screen Test will yield preliminary positive results when prescription drugs TCA, Barbiturates and Benzodiazepine, Methadone, Buprenorphine and Opiates are ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for TCA, Barbiturates and Benzodiazepine in urine.

The Advin Multi-Drug Screen Test provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical test result. Gas chromatography/mass spectrometry (GC/MS), Liquid Chromatography / Mass Spectrometry/Mass (LC/MS/MS) and High Performance Liquid Chromatography (HPLC) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in the evaluation of a preliminary positive test result.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K122809: Advin Multi-Drug Screen Test Cassette, Dip Card and Cup.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122809

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026